InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[BesaoT35]

The presentation is compelling. Thanks to Frankenstein for posting it. There are roughly 1,000 suitable patients in one year. We need 4 more to complete the study. The success so far in conversions has been with no stem cells at all just the scaffold yet it is successful. I have an intuition that stem cells and nerve growth factors could add substantially to successful outcomes but that could be just hopeful thinking on my part.

I do not know whether opting to be in the study means that patients could have all their treatments covered which might be an additional incentive for a patient to opt in.

4 more patients out of 1000 potential candidates does not seem so far fetched. I believe that they will achieve full enrollment and given the success of Inspire 1.0 that Inspire 2.0 should be successful enough also to get approved.

There are very few believers in NVIV at this time given the previous stock performance and Frank Reynolds former CEO that went to jail for fraud.

There is one analyst with a $30 price target.